Haemonetics Corp.
(NYSE : HAE)

( )
HAE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.03%535.631.0%$648.52m
DHRDanaher Corp. 0.36%252.780.7%$635.19m
MDTMedtronic Plc 1.28%90.340.6%$612.83m
ABTAbbott Laboratories 1.91%109.010.8%$601.34m
ISRGIntuitive Surgical, Inc. 0.30%202.590.8%$423.22m
BSXBoston Scientific Corp. 0.77%37.791.0%$333.72m
ALGNAlign Technology, Inc. 0.10%242.156.4%$293.90m
BDXBecton, Dickinson & Co. 1.93%249.251.0%$275.67m
EWEdwards Lifesciences Corp. 1.33%95.990.4%$271.04m
SYKStryker Corp. 0.89%198.861.3%$258.39m
IDXXIDEXX Laboratories, Inc. 2.58%358.223.8%$231.23m
AAgilent Technologies, Inc. 0.63%117.801.7%$206.87m
BAXBaxter International, Inc. 0.82%65.791.8%$203.09m
DXCMDexCom, Inc. 1.00%75.451.9%$174.20m
SWAVShockwave Medical, Inc. -0.60%194.370.0%$168.16m

Company Profile

Haemonetics Corp. is a global healthcare company, which engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.